![]() |
Volumn 85, Issue 3, 2002, Pages 507-510
|
Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: A Gynecologic Oncology Group study
a
|
Author keywords
Mitomycin + doxorubicin + cisplatin (MAP); Uterine leiomyosarcoma
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
MITOMYCIN;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXICITY;
FEMALE;
HUMAN;
HUMAN CELL;
LEIOMYOSARCOMA;
LEUKOPENIA;
LUNG TOXICITY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
UTERUS LEIOMYOSARCOMA;
UTERUS SARCOMA;
|
EID: 0036084166
PISSN: 00908258
EISSN: None
Source Type: Journal
DOI: 10.1006/gyno.2002.6661 Document Type: Article |
Times cited : (37)
|
References (23)
|